House Republicans pass spending bills with cuts to non-defense programs, but face Senate opposition. A prolonged battle and potential government shutdown looms.

Defense Secretary Lloyd Austin announced an additional $2.3 billion in military aid for Ukraine, including anti-tank weapons and air defense systems. The aid comes as Ukraine continues to battle...

The US is helping countries targeted by China's economic pressure, offering assistance to navigate trade disruptions and find alternative markets. Learn how a US team is combating China's tactics.

Boeing reported a USD 355 million loss in the first quarter, facing scrutiny over safety concerns and manufacturing issues following the Alaska Airlines incident. The company is focused on fixing...

India defended its coal use at COP28, arguing developed nations should not hinder developing countries' progress and that fossil fuel subsidies are needed for poverty eradication.

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

Ceigall India's Rs 1,253 crore IPO opens on August 1 with a price band of Rs 380-401 per share. The infrastructure company's issue includes fresh issuance and OFS. Learn more.

BHIVE Workspace leases 42,000 sq ft office space in Bengaluru from Brigade Group, expanding its presence in the city's key business hubs. The new facility will support 1200+ seats, reflecting the...

Central GST officers detected Rs 36,374 crore in fake ITC claims in FY24, a 51% increase from the previous year. The government is taking measures to combat this fraud.

Dr Reddy's Laboratories' biosimilar Rituximab, ITUXREDI, receives positive opinion from the European Medicines Agency (EMA), bringing it closer to launch in EU countries.

UltraTech Cement has confirmed that India Cements will remain a listed entity following its acquisition of a 32.72% stake. The open offer price is Rs 390 per share, and UltraTech intends to acquire...

RBI Governor highlights digitalisation's impact on banking, emphasizing next-generation services, affordable finance, and challenges like cybersecurity and data privacy.

Ceigall India's Rs 1,253 crore IPO opens on August 1 with a price band of Rs 380-401 per share. The infrastructure company's issue includes fresh issuance and OFS. Learn more.